Non-alcoholic Fatty Liver Disease: a Multi-system Disease Influenced by Ageing and Sex, and Affected by Adipose Tissue and Intestinal Function
Overview
Affiliations
In recent years, a wealth of factors are associated with increased risk of developing non-alcoholic fatty liver disease (NAFLD) and NAFLD is now thought to increase the risk of multiple extra-hepatic diseases. The aim of this review is first to focus on the role of ageing and sex as key, poorly understood risk factors in the development and progression of NAFLD. Secondly, we aim to discuss the roles of white adipose tissue (WAT) and intestinal dysfunction, as producers of extra-hepatic factors known to further contribute to the pathogenesis of NAFLD. Finally, we aim to summarise the role of NAFLD as a multi-system disease affecting other organ systems beyond the liver. Both increased age and male sex increase the risk of NAFLD and this may be partly driven by alterations in the distribution and function of WAT. Similarly, changes in gut microbiota composition and intestinal function with ageing and chronic overnutrition are likely to contribute to the development of NAFLD both directly (i.e. by affecting hepatic function) and indirectly via exacerbating WAT dysfunction. Consequently, the presence of NAFLD significantly increases the risk of various extra-hepatic diseases including CVD, type 2 diabetes mellitus, chronic kidney disease and certain extra-hepatic cancers. Thus changes in WAT and intestinal function with ageing and chronic overnutrition contribute to the development of NAFLD - a multi-system disease that subsequently contributes to the development of other chronic cardiometabolic diseases.
Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Orfanidou M, Polyzos S Medicina (Kaunas). 2025; 61(1).
PMID: 39859020 PMC: 11766779. DOI: 10.3390/medicina61010038.
Yu H, Su X, Tao W, Sun W, Zhang X, Han Q BMJ Open. 2024; 14(12):e087550.
PMID: 39672583 PMC: 11647396. DOI: 10.1136/bmjopen-2024-087550.
Nurkolis F, Utami T, Alatas A, Wicaksono D, Kurniawan R, Ratmandhika S Front Aging. 2024; 5:1462569.
PMID: 39484071 PMC: 11524912. DOI: 10.3389/fragi.2024.1462569.
Donghia R, Tatoli R, Campanella A, Losurdo G, Di Leo A, De Pergola G Nutrients. 2024; 16(19).
PMID: 39408202 PMC: 11478343. DOI: 10.3390/nu16193234.
Female obesity: clinical and psychological assessment toward the best treatment.
Guglielmi V, Dalle Grave R, Leonetti F, Solini A Front Endocrinol (Lausanne). 2024; 15:1349794.
PMID: 38765954 PMC: 11099266. DOI: 10.3389/fendo.2024.1349794.